KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Long-Term Debt Repayments (2016 - 2025)

Cvs Health (CVS) has disclosed Long-Term Debt Repayments for 15 consecutive years, with $20.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Debt Repayments fell 99.35% year-over-year to $20.0 million, compared with a TTM value of $3.6 billion through Dec 2025, down 23.97%, and an annual FY2025 reading of $3.6 billion, down 23.97% over the prior year.
  • Long-Term Debt Repayments was $20.0 million for Q4 2025 at Cvs Health, down from $2.8 billion in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $3.1 billion in Q4 2024 and bottomed at $14.0 million in Q1 2022.
  • Average Long-Term Debt Repayments over 5 years is $1.2 billion, with a median of $1.1 billion recorded in 2022.
  • The sharpest move saw Long-Term Debt Repayments skyrocketed 29575.0% in 2021, then plummeted 99.54% in 2022.
  • Year by year, Long-Term Debt Repayments stood at $2.4 billion in 2021, then tumbled by 99.34% to $16.0 million in 2022, then skyrocketed by 2600.0% to $432.0 million in 2023, then soared by 609.95% to $3.1 billion in 2024, then crashed by 99.35% to $20.0 million in 2025.
  • Business Quant data shows Long-Term Debt Repayments for CVS at $20.0 million in Q4 2025, $2.8 billion in Q3 2025, and $19.0 million in Q2 2025.